On March 27, 2024, Ayala Pharmaceuticals, Inc. and Roy Golan, Chief Financial Officer, agreed that Mr. Golan would depart the Company on June 25, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.665 USD | +19.82% | +16.26% | -0.30% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.30% | 28.35M | |
+0.17% | 42.86B | |
+10.92% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.23% | 25.15B | |
-24.79% | 18.63B | |
+26.69% | 12.37B | |
-3.13% | 11.92B | |
+6.57% | 11.21B |
- Stock Market
- Equities
- ADXS Stock
- News Ayala Pharmaceuticals, Inc.
- Ayala Pharmaceuticals, Inc. Announces Departure of Roy Golan as Chief Financial Officer, Effective from June 25, 2024